Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone rotation for uncontrolled mixed nociceptive and neuropathic cancer pain in palliative care
ACTRN12609001071213Phase 4Not yet recruiting
- Sponsor
- Brisbane South Palliative Care Collaborative
- Start
- Dec 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methadone in cancer pain, Neuralgia and nociceptive pain, sponsored by Brisbane South Palliative Care Collaborative. Primary endpoints: Mean difference in pain rating and Global impression of pain control. Planned start Dec 2009; status: not yet recruiting.
02
Drugs
methadone
03
Conditions
cancer painNeuralgianociceptive pain
Beyond the preview
Go deeper on ACTRN12609001071213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609001071213.